These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16628961)

  • 41. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
    Woodruff T
    Intern Med J; 2006 Dec; 36(12):797-8; author reply 798-9. PubMed ID: 17096747
    [No Abstract]   [Full Text] [Related]  

  • 42. The COX-2 controversy continues ...but NSAIDs are still in the lead. New studies shed light on risks associated with popular arthritis painkillers.
    Health News; 2006 Aug; 12(8):3-4. PubMed ID: 16913025
    [No Abstract]   [Full Text] [Related]  

  • 43. [Insight on the clinical pharmacology of non-steroidal anti-inflammatory drugs].
    Maddison JE
    Tijdschr Diergeneeskd; 2010 Jan; 135(2):54-8. PubMed ID: 20344966
    [No Abstract]   [Full Text] [Related]  

  • 44. COX-2 inhibition: what we learned--a controversial update on safety data.
    Katz JA
    Pain Med; 2013 Dec; 14 Suppl 1():S29-34. PubMed ID: 24373107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chemoprevention of colorectal cancer].
    Stelmaszuk T; Jałocha L; Wojtuń S; Gil J
    Pol Merkur Lekarski; 2009 May; 26(155):565-8. PubMed ID: 19606728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacology of selective inhibition of COX-2.
    Grosser T
    Thromb Haemost; 2006 Oct; 96(4):393-400. PubMed ID: 17003913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly.
    Stillman MJ; Stillman MT
    Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Back to the future: postoperative pain management beyond COX-2 inhibitors.
    Naesh O
    N Z Med J; 2006 Sep; 119(1242):U2170. PubMed ID: 16998571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analgesics, NSAIDS, and coxibs in rheumatic pain].
    Di Matteo L
    Reumatismo; 2006; 58 Spec No.1():84-9. PubMed ID: 23631071
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of rofecoxib in family practice in the north of Netherlands, 2000-2004: background and consequences].
    van der Veen WJ; van der Werf GT
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1016-21. PubMed ID: 16715866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future.
    Fiorucci S
    Gastroenterol Clin North Am; 2009 Jun; 38(2):315-32. PubMed ID: 19446261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.
    Chan FK
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):563-73. PubMed ID: 17008926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
    Lazzaroni M; Battocchia A; Bianchi Porro G
    Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease.
    Whelton A
    Am J Cardiol; 2006 May; 97(9A):3-9. PubMed ID: 16675316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. To use or not to use: the dilemma of NSAIDs and craniotomy.
    Umamaheswara Rao GS; Gelb AW
    Eur J Anaesthesiol; 2009 Aug; 26(8):625-6. PubMed ID: 19584610
    [No Abstract]   [Full Text] [Related]  

  • 56. Nonsteroidal antiinflammatory drugs: past, present and future.
    Patrono C; Rocca B
    Pharmacol Res; 2009 May; 59(5):285-9. PubMed ID: 19416627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [NSAIDs and coxibs raise blood pressure].
    Krankenpfl J; 2005; 43(7-10):199. PubMed ID: 16515271
    [No Abstract]   [Full Text] [Related]  

  • 58. Mayo Clinic office visit. NSAIDs and cardiovascular risks. An interview with Sharon Mulvagh, M.D.
    Mulvagh S
    Mayo Clin Womens Healthsource; 2010 Nov; 14(11):6. PubMed ID: 20881928
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk-benefit perspectives in COX-2 blockade.
    Dabu-Bondoc S; Franco S
    Curr Drug Saf; 2008 Jan; 3(1):14-23. PubMed ID: 18690976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pain, analgesics, and the cardiovascular system.
    Wehrmacher WH; Messmore HL; Haque W
    Compr Ther; 2006; 32(4):236-9. PubMed ID: 17898429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.